Integrichain Blog

Blog

Contracts & Pricing Brendan Crabtree Jillian Murray
November 23, 2021

Regulatory Updates

4 Minute Read

This month we discuss COVID-19 vaccine mandates, the recent HHS drug discount ruling, and Medicare drug price reforms.

Contracts & Pricing Ben Fanelli Kevin Ehmann
October 20, 2021

The New Plan for Addressing High Drug Prices

4 Minute Read

We discuss the Biden administration's plan for combatting high drug prices, the new PBM public law reporting cycle, and MA and Part D rule for 2022.

Contracts & Pricing Brendan Crabtree Kevin Ehmann
September 17, 2021

How Discount Cards Are Replacing PBMs

3 Minute Read

We review how discount cards have disrupted the prescription market as well as updates to the most-favored-nation pricing model and new STPR laws in Maine.

Contracts & Pricing Ben Fanelli
August 13, 2021

Compliance Guidelines for Government Programs

5 Minute Read

Six key elements to operate an effective compliance program. Also, new VA FSS rules for vaccine drugs, State Price Transparency, and Medicare Part D updates and reminders.

Contracts & Pricing Gourab Khan
July 26, 2021

The Branded Pharma Fee Deadline Approaches

4 Minute Read

We'll tell you how to prepare. Plus new manufacturer awareness for orphan drugs, midnight changes to MDRP, and upholding the ACA.

Contracts & Pricing Rupal Patel
June 29, 2021

SPTR, CMS Final Rule & VA Public Law Updates

5 Minute Read

The latest regulatory updates and reporting reminders for June 2021.

Contracts & Pricing Jillian Murray Brendan Crabtree
May 27, 2021

Making Sense of Co-Pay Offset Programs

4 Minute Read

We dive into the specifics of co-pay offset programs and also examine updates to 340B administrative dispute resolution and ASP reporting as per H.R. 133.

Contracts & Pricing Brendan Crabtree
April 21, 2021

Updates to State Price Transparency Reporting, Medicaid Laws

3 Minute Read

Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.

Contracts & Pricing Rupal Patel John Whitridge
April 14, 2021

The Current State of Drug Price Transparency Reporting

2 Minute Read

What you need to know about navigating a patchwork of state policies, achieving operational readiness, and avoiding compliance risk.

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand